BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
52 hedge funds and large institutions have $16.9M invested in BRAINSTORM CELL THERAPUTC in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
67% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 24
Holders
52
Holding in Top 10
–
Calls
$3.84M
Puts
$3.62M
Top Buyers
| 1 | +$771K | |
| 2 | +$369K | |
| 3 | +$353K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$129K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.7K |
Top Sellers
| 1 | -$834K | |
| 2 | -$730K | |
| 3 | -$340K | |
| 4 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$331K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$284K |